After Harvard resigned, students and doctors thought about medical school rankings.

Published Date: 22 Apr 2023

The US News and World Report rankings, once the benchmark by which students evaluated medical schools, have recently begun to lose some of their sway. The value of a school can be evaluated in various ways, according to medical students.

Read Full News

Latest News

Who’s In Charge in the ICU? Families Need to Know

In the Arab region, families often meet intensivists for the first time in a crisis — adding confusion when trust and clear ICU decisions matter most.

JAK Inhibitors: Putting Safety Concerns in Context

After a study revealed higher cancer and other risks with a JAK inhibitor in patients with rheumatoid arthritis, further evidence suggests that the risks may be lower in dermatology.

High-Dose Flu Vaccine Linked to Lower Dementia Risk

Vaccination with a higher dose of the influenza vaccine may reduce the risk of developing dementia among older adults.

New Drugs Are Primary Care Game Changers, but Pricey

Four recent approvals are poised to affect patient care.

Life-Extending Bile Duct Cancer Drug Cleared for NHS Use

NICE has recommended zanidatamab for HER2-positive biliary tract cancer in final draft guidance, offering patients more time and better quality of life.

SARS-CoV-2 Tied to Higher Respiratory Failure Risk Than Flu

Hospitalised adults with SARS-CoV-2, parainfluenza virus, or RSV vs influenza A/B infection experience greater acute respiratory failure, with those with SARS-CoV-2 infection having the greatest risk.

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Latest News

In the Arab region, families often meet intensivists for the first time in a crisis — adding confusion when trust and clear ICU decisions matter most.

After a study revealed higher cancer and other risks with a JAK inhibitor in patients with rheumatoid arthritis, further evidence suggests that the risks may be lower in dermatology.

Vaccination with a higher dose of the influenza vaccine may reduce the risk of developing dementia among older adults.

Four recent approvals are poised to affect patient care.

NICE has recommended zanidatamab for HER2-positive biliary tract cancer in final draft guidance, offering patients more time and better quality of life.

Hospitalised adults with SARS-CoV-2, parainfluenza virus, or RSV vs influenza A/B infection experience greater acute respiratory failure, with those with SARS-CoV-2 infection having the greatest risk.

News All Time

Dendritic Cell Strategies May Reduce Cancer Recurrence Risk

Dendritic cells within tumors may enable personalized immunotherapy strategies that reduce the risk for cancer relapses by strengthening immune memory.

Sunflower Seed Sensitization Outpaces True Allergy in Kids

More than 80% of children sensitized to sunflower seeds and advised to avoid them can tolerate the seeds during an oral food challenge.

Adding Steroid Shows No Heart Benefit in Kawasaki Disease

Adding prednisolone to the standard treatment for Kawasaki disease in children does not lower the incidence of coronary artery lesions at 1 month after illness onset, according to a phase 3 trial.

Torque Teno Virus Predicts Malignancy Post-Kidney Transplant

Higher torque teno virus loads during the first year after kidney transplant are associated with an increased risk for malignancies in subsequent years, a prospective study finds.

Allergy Myths Abound on Social Media: Debunk With Care

From probiotics to do-it-yourself IgG test kits, social media is misinforming patients about how to diagnose and manage allergies.

Precision Medicine for Rare Allergies

New biologics, precision diagnostics, and AI are reshaping care for rare allergies — from eosinophilic esophagitis to drug hypersensitivity — moving practice toward personalized treatment.

NICE Backs Belantamab Mafodotin for Relapsed Myeloma

NICE has recommended belantamab mafodotin for relapsed multiple myeloma, with trial data showing remissions of more than 3 years.

Study Identifies Novel Stress-Inflammation Pathway in AD

Most patients and doctors know that stress exacerbates AD. A new study pinpoints a neural mechanism that may be involved in this process.

Scotland Backs New Immunotherapy in Advanced Cervical Cancer

The Scottish Medicines Consortium has accepted pembrolizumab with chemoradiotherapy for high-risk, locally advanced cervical cancer in Scotland.

Eye Shingles Tied to Cancer Risk in Those With Immune Issues

Herpes zoster ophthalmicus is associated with an increased risk for subsequent malignancy among individuals with an underlying history of immune dysregulation, according to a recent cohort study.

Novo Nordisk Weight-loss Drug Shows Liver Benefits in Mouse Study

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)

SLIT Adherence May Lower Rhinitis Severity in Children

Higher adherence to sublingual pollen immunotherapy in children with allergic rhinitis is linked to lower odds of severe rhinitis.

Schistosomiasis: Four Things You May Not Know

From Ancient Egypt to Modern China, how parasitic worms have shaped human health and world history.

C auris Is Now Endemic in Europe. Can It Be Contained?

The fungus, identified only 20 years ago, is endemic in healthcare facilities of five European countries. What can be done to stop its spread?

New Pulmonary Embolism Clinical Categories PCPs Should Know

Dr Nina Lum discusses key takeaways of new PE clinical categories for primary care physicians and providers.

Amgen's Lung Cancer Drug Tarlatamab Wins China Approval

Amgen's lung cancer drug tarlatamab has won ⁠approval from China's National Medical Products Administration.

Recommended News For You

A Possible Novel CAR-T Treatment for High-Risk R/R Follicular Lymphoma May Be Liso-Cel.

Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.

Delaying Pegfilgrastim May Curb Bone Pain in Breast Cancer

Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'

Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.

Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.

New PET tracer enables same-day imaging of triple-negative breast and urothelial cancers

Recommended Articles For You

Examining Serum Osmolality: What It Is And How To Test For It 

Different Types of Blood Dyscrasias  

Discovering the Benefits of TNK: A Comprehensive Blog Article  

Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Millions of men could benefit from faster scan to diagnose prostate cancer

2.

Prostate cancer screening seems to be improved by PSA, biomarker testing, and MRI combined.

3.

Living near St. Louis-area Coldwater Creek during childhood linked with higher risk of cancer from radiation

4.

Guidelines for cervical cancer screening and the risk of preterm birth in young women.

5.

In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.

1.

What You Need To Know About Secondary Polycythemia: Treatment & Symptoms

2.

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage

3.

Revolutionizing Cancer Treatment: ESMO's Updated Recommendations for Tumour NGS

4.

The Mysterious Pain of Scrotal Hematoma: A Guide to Diagnosis and Treatment

5.

Radiation in Oncology: Advances, Applications, and Accessibility

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective

2.

ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot